DRNA - Dicerna Pharmaceuticals Stock Trading

Dicerna Pharmaceuticals Inc.(NASDAQ: DRNA) stock trading, description, contact, officers and directors.

About Dicerna Pharmaceuticals Inc.

Not available

Stock Information

Dicerna Pharmaceuticals Inc. Company Name:

DRNA Stock Symbol:

NASDAQ Market:

DRNA - Dicerna Pharmaceuticals Stock Trading

Get DRNA Alerts

News, Short Squeeze, Breakout and More Instantly...

DRNA - Royalty Pharma Acquires OXLUMO(TM) Royalty Interest From Dicerna for up to $240 Million

Dicerna to receive $180 million upfront and up to $60 million in potential additional milestone payments NEW YORK and LEXINGTON, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) (“Royalty Pharma”) and Dicerna Pharmaceuticals, Inc. (Nasdaq...
DRNA - Dicerna Sells OXLUMO(TM) (lumasiran) Royalty Interest to Royalty Pharma for Up to $240 Million

– Dicerna To Receive $180 Million Upfront and Up to $60 Million in Potential Additional Milestone Payments – Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (“Dicerna”) and Royalty Pharma plc (Nasdaq: RPRX) (“Royalty Pharma”) to...
DRNA - Dicerna's GalXC-Plus(TM) RNAi Technology Delivers Target Knockdown Across CNS and to Specific CNS Cell Types in Preclinical Studies

Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced new data from preclinical studies of its GalXC-Plus™ RNAi technolog...